1. Pink Sheet

Acetaminophen Overdose Risk Persists Despite Label Changes – Study

 
• By Elizabeth Crawford

Many consumers do not closely read OTC painkiller labels and often do not adhere to package or label instructions, researchers say. Many likely are unaware of or ignore label changes industry voluntarily made and FDA ordered to reduce the risk of liver toxicity due to unintentional overdose.

The addition of liver toxicity and overdose risk warnings to acetaminophen labels may not be enough to reduce the high prevalence of overdosing of the painkiller, say researchers in a recent study.

The authors state in the May 26 Journal of General Internal Medicine that interviews with 500 adults between September 2009...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Pink Sheet

COVID-19 mRNA Vaccine Labels Now Quantify Myocarditis Risk, But ACIP Wants Other Changes

 
• By Sue Sutter

New members of the CDC’s Advisory Committee on Immunization Practices suggested concerns beyond myocarditis, questioning whether test-negative observational studies are giving an incorrect picture of effectiveness.

Medicare’s Combo Products Negotiation Plan Conflicts With US FDA Standards, Firms Argue

 
• By Cathy Kelly

The plan could curtail a period of pricing flexibility for newer subcutaneous versions of important oncology drugs.

EU Pharma Overhaul May Reshape Aspects Of Drug Promotion And HCP Partnerships

 
• By Eliza Slawther

Lawyers explain how changes to rules around drug advertising and promotional activities under the EU pharma reform package could impact companies operating in the bloc, with one legal expert advising companies to “monitor developments closely.”